Joey Weng, MD, MPH, FAAFP (@brycechipmunk) profile picture

Physician/Epidemiologist/Associate professor @BrownMedicine Opinions are my own

United States
Joined May 2009
Photo by Joey Weng, MD, MPH, FAAFP (@brycechipmunk)Photo by Joey Weng, MD, MPH, FAAFP (@brycechipmunk)Photo by Joey Weng, MD, MPH, FAAFP (@brycechipmunk)
New editorial: As CGRP-targeted therapies gain widespread use for migraine prevention, understanding their potential impact on glaucoma and ocular health is an important emerging research priority. #CGRP #Glaucoma #Migraine tandfonline.com/doi/10.1080/…
2
33
We found that GLP-1 receptor agonists were associated with a lower risk of age-related macular degeneration (especially dry AMD) in adults with diabetes and obesity compared with metformin or other weight-loss medications. #RWE #GLP1 amjmed.com/article/S0002-934…
14
Are glaucoma drug spending disparities due to use or price? Our Ophthalmology Glaucoma study finds differences are driven by price—not utilization in Medicare Part D. Implications for policy & equity. #Glaucoma #HealthPolicy sciencedirect.com/science/ar…
15
Joey Weng, MD, MPH, FAAFP retweeted
A calcitonin gene-related peptide inhibitor appears to lower the three-year risk of incident #glaucoma in adults with #migraine: hubs.la/Q04nrPf-0 #NeuroTwitter #CGRP @AndrewGoLeeMD @brycechipmunk
1
3
8
976
Joey Weng, MD, MPH, FAAFP retweeted
Class II evidence that CGRP inhibitor (CGRPi) users with migraine have a lower risk of incident glaucoma when compared with non-CGRPi users with #migraine: hubs.ly/Q04jpjcG0
7
1
23
5,968
New in IOVS: Denosumab (RANKL inhibitor) was linked to lower risk of OHT (HR 0.72) & POAG (HR 0.63) vs bisphosphonates. Another signal connecting systemic therapy & eye disease. #Glaucoma #IOVS #RealWorldData iovs.arvojournals.org/articl…
11
Joey Weng, MD, MPH, FAAFP retweeted
Chien-Chih Chou from the National Yang Ming Chiao Tung University investigate RANKL inhibition and the risk of ocular hypertension and primary open-angle glaucoma. doi.org/10.1167/iovs.67.6.8
1
99
In >14K patients with dry eye disease, omega-3 supplementation was linked to lower glaucoma risk
– POAG HR 0.45
– Total glaucoma HR 0.48 Another signal connecting metabolism & eye disease. #Glaucoma #Omega3 #Ophthalmology tvst.arvojournals.org/articl…
12
New in TVST: PCSK9 inhibitors were associated with lower risk of AMD (esp. dry AMD) vs statins in a large real-world cohort. More evidence linking lipid pathways & retinal disease—needs confirmation. #AMD #PCSK9 #Ophthalmology tvst.arvojournals.org/articl…
25
Joey Weng, MD, MPH, FAAFP retweeted
📢 “While this does not support using #CGRP inhibitors for #glaucoma prevention, it provides additional safety reassurance and highlights a potential link between #migraine biology and ocular disease,” said @brycechipmunk. Read the full summary here👇 vist.ly/54as3
1
2
42
Joey Weng, MD, MPH, FAAFP retweeted
A new study co-authored by clinical associate professor of #FamilyMedicine, Chien-Hsiang Weng highlights a potential link between migraine treatment and reduced glaucoma risk. The research found that adults using calcitonin gene-related peptide inhibitors (CGRPi), particularly monoclonal antibody therapies, experienced a lower risk of developing glaucoma compared with those using other preventive migraine medications. Read the full study published by the American Academy of Neurology (AAN) Neurology Journal: neurology.org/doi/10.1212/WN…
1
2
41
Joey Weng, MD, MPH, FAAFP retweeted
New study published in @GreenJournal: Certain #migraine prevention drugs associated with reduced risk of #glaucoma. hubs.ly/Q04fJ9rG0 #AANscience #Neurology
4
1
9
1,416